Trial Profile
Post-Marketing Study of FOLFIRI Therapy + Avastin (Bevacizumab) in Patients with Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 31 May 2016 New trial record